Form 4: Eastman Chemical Co. Executive Brian Travis Smith Reports Stock Option Grant and Restricted Stock Units Acquisition
SEC Form 4 Filing
Brian Travis Smith, SVP at Eastman Chemical Co., reports the acquisition of stock options and restricted stock units.
Summary
- Brian Travis Smith, a Senior Vice President at Eastman Chemical Co. (EMN), filed a Form 4 with the SEC.
- The filing reports the grant of employee stock options and restricted stock units.
- On February 27, 2024, Smith acquired 21,182 employee stock options with an exercise price of $86.15.
- These options vest in three equal installments starting February 27, 2025.
- Smith also acquired 4,288 restricted stock units, which will vest and payout in unrestricted shares of Eastman Chemical Co. common stock on February 27, 2027, subject to continued employment.
Sentiment
Score: 6
Explanation: The document is a routine SEC filing regarding executive compensation, which is neither particularly positive nor negative. It's a neutral event in the context of the company's overall performance.
Positives
- The grant of stock options and restricted stock units aligns the executive's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Future Outlook
The document does not contain specific forward-looking statements regarding the company's future performance.
Industry Context
Executive compensation through stock options and restricted stock units is a common practice in the chemical industry to incentivize performance and retain key personnel.
Comparison to Industry Standards
- Companies like Dow, BASF, and LyondellBasell also utilize stock options and restricted stock units as part of their executive compensation packages.
- The vesting schedules and grant sizes are generally aligned with industry norms for companies of similar size and market capitalization.
Stakeholder Impact
- Shareholders may view the equity grants as a positive sign, aligning management's interests with the company's long-term success.
- Employees may see the grants as a reflection of the company's commitment to its leadership team.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of the transaction: grant of stock options and restricted stock units. |
| 02/27/2025 | First vesting date for one-third of the stock options. |
| 02/27/2026 | Second vesting date for one-third of the stock options. |
| 02/27/2027 | Final vesting date for the remaining stock options and the restricted stock units. |
| 02/29/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.